SCHEMBL6755812

SCHEMBL6755812

CC(=O)Cc1ccc(O)c(CN2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.50
▸ POLB P06746 1/20 0.50
▸ KMT2A Q03164 6/20 0.47
▸ HDAC1 Q13547 2/20 0.47
▸ HDAC7 Q8WUI4 2/20 0.47
▸ PKM P14618 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ HTT P42858 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ RGS12 O14924 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ ALOX15 P16050 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2988721 0.88 KMT2A (0.51) HPGDPOLBKMT2AHDAC1HDAC7
SCHEMBL27766198 0.78 KMT2A (0.49) HPGDPOLBKMT2APKMTSHR
SCHEMBL31751934 0.76 KMT2A (0.65) HPGDPOLBKMT2AHDAC1HDAC7
SCHEMBL6076008 0.76 GRM5 (0.62) HPGDKMT2ASMN1; SMN2CA12CA1
SCHEMBL12905303 0.75 HDAC1 (0.68) HPGDPOLBKMT2AHDAC1HDAC7
SCHEMBL15624560 0.74 MPO (0.50) KMT2AHDAC1HDAC7PKMTSHR
SCHEMBL10200857 0.73 CASP3 (0.55) HPGDPOLBKMT2AHDAC1HDAC7
SCHEMBL31753192 0.71 KMT2A (0.55) HPGDPOLBKMT2AHDAC1HDAC7
SCHEMBL6675322 0.71 KDM4E (0.59) HPGDKMT2ACA12CA1CA2
SCHEMBL21087120 0.71 ALDH1A1 (0.49) HPGDPOLBKMT2AHDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 — — US disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 — — US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 — — US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 HPGD 4010/4885POLB 3654/4885KMT2A 505/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 HPGD 4010/4885POLB 3654/4885KMT2A 505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback